Imrevla Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 15 years ago on Monday, May 25, 2009, according to the United State Patent & Trademark Office
Word Mark Imrevla
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 78688223
Status Date Monday, May 25, 2009
Filing Date Monday, May 25, 2009
Attorney Nadine P. Flynn

Correspondent

Nadine P. Flynn
BRISTOL-MYERS SQUIBB COMPANY
Trademark Department
345 PARK AVE
NEW YORK NY 10154-0004

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, August 15, 2005
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.